{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:32:29Z","timestamp":1788877949777,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01059-y","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T08:15:48Z","timestamp":1768378548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigating the impact of gut microbiota-derived metabolites on benign prostatic hyperplasia using network pharmacology approaches"],"prefix":"10.1186","volume":"27","author":[{"given":"Yuanzhao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyue","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"3","key":"1059_CR1","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/med.21778","volume":"41","author":"C Fang","year":"2021","unstructured":"Fang C, Wu L, Zhu C, Xie WZ, Hu H, Zeng XT. A potential therapeutic strategy for prostatic disease by targeting the oral microbiome. Med Res Rev. 2021;41(3):1812\u201334. https:\/\/doi.org\/10.1002\/med.21778.","journal-title":"Med Res Rev"},{"issue":"4","key":"1059_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bju.15229","volume":"127","author":"CM Devlin","year":"2021","unstructured":"Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia - what do we know? BJU Int. 2021;127(4):389\u201399. https:\/\/doi.org\/10.1111\/bju.15229.","journal-title":"BJU Int"},{"key":"1059_CR3","doi-asserted-by":"publisher","unstructured":"Yu SH, Jung SI. The potential role of urinary microbiome in benign prostate Hyperplasia\/Lower urinary tract symptoms. Diagnostics (Basel). 2022;12(8). https:\/\/doi.org\/10.3390\/diagnostics12081862.","DOI":"10.3390\/diagnostics12081862"},{"issue":"2","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"261\u2013270.10.1515","DOI":"10.1515\/reveh-2020-0051","volume":"36","author":"A Shah","year":"2021","unstructured":"Shah A, Shah AA, K N, Lobo R. Mechanistic targets for BPH and prostate cancer-a review. Rev Environ Health. 2021;36(2):261\u2013270. https:\/\/doi.org\/10.1515\/reveh-2020-0051.","journal-title":"Rev Environ Health"},{"issue":"4\u20135","key":"1059_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.diff.2011.04.006","volume":"82","author":"TM Nicholson","year":"2011","unstructured":"Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation. 2011;82(4\u20135):184\u201399. https:\/\/doi.org\/10.1016\/j.diff.2011.04.006.","journal-title":"Differentiation"},{"issue":"6","key":"1059_CR6","doi-asserted-by":"publisher","first-page":"E1182","DOI":"10.1152\/ajpendo.00338.2019","volume":"317","author":"H Collden","year":"2019","unstructured":"Collden H, Landin A, Wallenius V, Elebring E, Fandriks L, Nilsson ME, Ryberg H, Poutanen M, Sjogren K, Vandenput L, Ohlsson C. The gut microbiota is a major regulator of androgen metabolism in intestinal contents. Am J Physiol Endocrinol Metab. 2019;317(6):E1182\u20131192. https:\/\/doi.org\/10.1152\/.00338.2019.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1059_CR7","doi-asserted-by":"publisher","unstructured":"Li J, Li Y, Zhou L, Li C, Liu J, Liu D, Fu Y, Wang Y, Tang J, Zhou L, Tan S, Wang L. The human microbiome and benign prostatic hyperplasia: current understandings and clinical implications. Microbiol Res. 2024;281. https:\/\/doi.org\/10.1016\/j.micres.2023.127596.","DOI":"10.1016\/j.micres.2023.127596"},{"issue":"1","key":"1059_CR8","doi-asserted-by":"publisher","first-page":"146\u2013158.10.1136","DOI":"10.1136\/gutjnl-2011-301805","volume":"62","author":"P Lepage","year":"2013","unstructured":"Lepage P, Leclerc MC, Joossens M, Mondot S, Blottiere HM, Raes J, Ehrlich D, Dore J. A metagenomic insight into our gut\u2019s microbiome. Gut. 2013;62(1):146\u2013158. https:\/\/doi.org\/10.1136\/gutjnl-2011-301805.","journal-title":"Gut"},{"issue":"8","key":"1059_CR9","doi-asserted-by":"publisher","first-page":"1221\u20131238.10.12","DOI":"10.1210\/me.2014-1108","volume":"28","author":"G Clarke","year":"2014","unstructured":"Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28(8):1221\u20131238. https:\/\/doi.org\/10.1210\/me.2014-1108.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"1059_CR10","doi-asserted-by":"publisher","first-page":"779\u2013792.10.1038","DOI":"10.1038\/s41385-020-00372-5","volume":"14","author":"B Jones-Freeman","year":"2021","unstructured":"Jones-Freeman B, Chonwerawong M, Marcelino VR, Deshpande AV, Forster SC, Starkey MR. The microbiome and host mucosal interactions in urinary tract diseases. Mucosal Immunol. 2021;14(4):779\u2013792. https:\/\/doi.org\/10.1038\/s41385-020-00372-5.","journal-title":"Mucosal Immunol"},{"key":"1059_CR11","doi-asserted-by":"publisher","unstructured":"Kruslin B, Tomas D, Dzombeta T, Milkovic-Perisa M, Ulamec M. Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach. Front Oncol. 2017;7. https:\/\/doi.org\/10.3389\/fonc.2017.00077.","DOI":"10.3389\/fonc.2017.00077"},{"key":"1059_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","volume":"111","author":"DM Golombos","year":"2018","unstructured":"Golombos DM, Ayangbesan A, O\u2019Malley P, Lewicki P, Barlow L, Barbieri CE, Chan C, DuLong C, Abu-Ali G, Huttenhower C, Scherr DS. The role of gut microbiome in the pathogenesis of prostate cancer: a prospective, Pilot study. Urology. 2018;111:122\u20138. https:\/\/doi.org\/10.1016\/j.urology.2017.08.039.","journal-title":"Urology"},{"key":"1059_CR13","doi-asserted-by":"publisher","first-page":"1248381.10.3389","DOI":"10.3389\/fcimb.2023.1248381","volume":"13","author":"D Xia","year":"2023","unstructured":"Xia D, Wang J, Zhao X, Shen T, Ling L, Liang Y. Association between gut microbiota and benign prostatic hyperplasia: a two-sample mendelian randomization study. Front Cell Infect Microbiol. 2023;13:1248381. https:\/\/doi.org\/10.3389\/fcimb.2023.1248381.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"98\u2013105.10.1055\/","DOI":"10.1055\/s-0042-121493","volume":"125","author":"W Huang","year":"2017","unstructured":"Huang W, Guo HL, Deng X, Zhu TT, Xiong JF, Xu YH, Xu Y. Short-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharide. Exp Clin Endocrinol Diabetes. 2017;125(2):98\u2013105. https:\/\/doi.org\/10.1055\/s-0042-121493.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"22","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"1481.10.21037\/a","DOI":"10.21037\/atm-20-6717","volume":"8","author":"L Li","year":"2020","unstructured":"Li L, Li C, Lv M, Hu Q, Guo L, Xiong D. Correlation between alterations of gut microbiota and miR-122-5p expression in patients with type 2 diabetes mellitus. Ann Transl Med. 2020;8(22):1481. https:\/\/doi.org\/10.21037\/atm-20-6717.","journal-title":"Ann Transl Med"},{"issue":"4","key":"1059_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.108.00802","volume":"60","author":"LA Stoddart","year":"2008","unstructured":"Stoddart LA, Smith NJ, Milligan G. International Union of pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol Rev. 2008;60(4):405\u201317. https:\/\/doi.org\/10.1124\/pr.108.00802.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"1059_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/21623945.2016.1252011","volume":"5","author":"E Heimann","year":"2016","unstructured":"Heimann E, Nyman M, Palbrink AK, Lindkvist-Petersson K, Degerman E. Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes. Adipocyte. 2016;5(4):359\u201368. https:\/\/doi.org\/10.1080\/21623945.2016.1252011.","journal-title":"Adipocyte"},{"issue":"12","key":"1059_CR18","doi-asserted-by":"publisher","first-page":"706\u2013718.10.1038","DOI":"10.1038\/s41585-023-00795-2","volume":"20","author":"N Pernigoni","year":"2023","unstructured":"Pernigoni N, Guo C, Gallagher L, Yuan W, Colucci M, Troiani M, Liu L, Maraccani L, Guccini I, Migliorini D, de Bono J, Alimonti A. The potential role of the microbiota in prostate cancer pathogenesis and treatment. Nat Rev Urol. 2023;20(12):706\u2013718. https:\/\/doi.org\/10.1038\/s41585-023-00795-2.","journal-title":"Nat Rev Urol"},{"issue":"9351","key":"1059_CR19","doi-asserted-by":"publisher","first-page":"60\u201362.10.1016\/S","DOI":"10.1016\/S0140-6736(03)12164-2","volume":"361","author":"VS Kassabian","year":"2003","unstructured":"Kassabian VS. Sexual function in patients treated for benign prostatic hyperplasia. Lancet. 2003;361(9351):60\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(03)12164-2.","journal-title":"Lancet"},{"issue":"4","key":"1059_CR20","doi-asserted-by":"publisher","first-page":"212\u2013218.10.1007","DOI":"10.1007\/s11884-010-0067-2","volume":"5","author":"JK Parsons","year":"2010","unstructured":"Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010;5(4):212\u2013218. https:\/\/doi.org\/10.1007\/s11884-010-0067-2.","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"1059_CR21","doi-asserted-by":"publisher","unstructured":"Chen J, Chen B, Lin B, Huang Y, Li J, Li J, Chen Z, Wang P, Ran B, Yang J, Huang H, Liu L, Wei Q, Ai J, Cao D. The role of gut microbiota in prostate inflammation and benign prostatic hyperplasia and its therapeutic implications. Heliyon. 2024;10(19):e38302. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38302.","DOI":"10.1016\/j.heliyon.2024.e38302"},{"issue":"2","key":"1059_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, Schmidt H. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 2022;43(2):136\u201350. https:\/\/doi.org\/10.1016\/j.tips.2021.11.004.","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"1059_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/13685538.2018.1519014","volume":"23","author":"K Sreenivasulu","year":"2020","unstructured":"Sreenivasulu K, Nandeesha H, Dorairajan LN, Nachiappa Ganesh R. Over expression of PI3K-AkT reduces apoptosis and increases prostate size in benign prostatic hyperplasia. Aging Male. 2020;23(5):440\u20136. https:\/\/doi.org\/10.1080\/13685538.2018.1519014.","journal-title":"Aging Male"},{"issue":"1","key":"1059_CR24","doi-asserted-by":"publisher","first-page":"7718.10.1038\/s4","DOI":"10.1038\/s41598-018-26143-8","volume":"8","author":"T Dang","year":"2018","unstructured":"Dang T, Liou GY. Macrophage cytokines enhance cell proliferation of normal prostate epithelial cells through activation of ERK and Akt. Sci Rep. 2018;8(1):7718. https:\/\/doi.org\/10.1038\/s41598-018-26143-8.","journal-title":"Sci Rep"},{"issue":"11","key":"1059_CR25","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.cellsig.2010.06.014","volume":"22","author":"A Starsichova","year":"2010","unstructured":"Starsichova A, Lincova E, Pernicova Z, Kozubik A, Soucek K. TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells. Cell Signal. 2010;22(11):1734\u201344. https:\/\/doi.org\/10.1016\/j.cellsig.2010.06.014.","journal-title":"Cell Signal"},{"issue":"5","key":"1059_CR26","doi-asserted-by":"publisher","first-page":"359\u2013366.10.4321","DOI":"10.4321\/s0004-06142009000500005","volume":"62","author":"JR Cansino Alcaide","year":"2009","unstructured":"Cansino Alcaide JR, Vera San Martin R, Rodriguez de BethencourtCodes F, Bouraoui Y, Rodriguez Berriguete G, Oueslati R, Perez-Utrilla M, De la Pena Barthel J, Paniagua Gomez-Alvarez R, Royuela Garcia M. [Prostatic specific antigen (PS), pro-inflammatory cytokines, and prostatic pathology (benign prostatic hyperplasia and cancer). Relatsh With Malignancy], Arch Esp Urol. 2009;62(5):359\u2013366. https:\/\/doi.org\/10.4321\/s0004-06142009000500005.","journal-title":"Relatsh With Malignancy], Arch Esp Urol"},{"issue":"5","key":"1059_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/aje\/kwp406","volume":"171","author":"JM Schenk","year":"2010","unstructured":"Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, Kratz M, Thompson IM. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol. 2010;171(5):571\u201382. https:\/\/doi.org\/10.1093\/aje\/kwp406.","journal-title":"Am J Epidemiol"},{"key":"1059_CR28","doi-asserted-by":"crossref","unstructured":"Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095-2147.","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095"},{"issue":"2","key":"1059_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3347\/kjp.2016.54.2.123","volume":"54","author":"SS Kim","year":"2016","unstructured":"Kim SS, Kim JH, Han IH, Ahn MH, Ryu JS. Inflammatory responses in a benign prostatic hyperplasia epithelial cell line (BPH-1) infected with Trichomonas vaginalis. Korean J Parasitol. 2016;54(2):123\u201332. https:\/\/doi.org\/10.3347\/kjp.2016.54.2.123.","journal-title":"Korean J Parasitol"},{"key":"1059_CR30","doi-asserted-by":"publisher","unstructured":"Fowke JH, Koyama T, Fadare O, Clark PE. Does inflammation mediate the obesity and BPH relationship? An epidemiologic analysis of body composition and inflammatory markers in blood, urine, and prostate tissue, and the relationship with prostate enlargement and lower urinary tract symptoms. PLoS One. 2016;11(6):e0156918. https:\/\/doi.org\/10.1371\/journal.pone.0156918.","DOI":"10.1371\/journal.pone.0156918"},{"key":"1059_CR31","doi-asserted-by":"publisher","unstructured":"Gu NY, Kim JH, Han IH, Im SJ, Seo MY, Chung YH, Ryu JS. Trichomonas vaginalis induces IL-1beta production in a human prostate epithelial cell line by activating the NLRP3 inflammasome via reactive oxygen species and potassium ion efflux. Prostate. 2016;76(10):885\u201396. https:\/\/doi.org\/10.1002\/pros.23178.","DOI":"10.1002\/pros.23178"},{"key":"1059_CR32","doi-asserted-by":"publisher","first-page":"37.10.1186\/s129","DOI":"10.1186\/s12950-015-0082-3","volume":"12","author":"M Kashyap","year":"2015","unstructured":"Kashyap M, Pore S, Wang Z, Gingrich J, Yoshimura N, Tyagi P. Inflammasomes are important mediators of prostatic inflammation associated with BPH. J Inflamm (Lond). 2015;12:37. https:\/\/doi.org\/10.1186\/s12950-015-0082-3.","journal-title":"J Inflamm (lond)"},{"issue":"10","key":"1059_CR33","doi-asserted-by":"publisher","first-page":"1193-1202.10.11","DOI":"10.1158\/1541-7786.MCR-13-0145","volume":"11","author":"L Ponomareva","year":"2013","unstructured":"Ponomareva L, Liu H, Duan X, Dickerson E, Shen H, Panchanathan R, Choubey D. AIM2, an IFN-inducible cytosolic DNA sensor, in the development of benign prostate hyperplasia and prostate cancer. Mol Cancer Res. 2013;11(10):1193\u20131202. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0145.","journal-title":"Mol Cancer Res"},{"key":"1059_CR34","doi-asserted-by":"publisher","unstructured":"Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 2002;17(4):525-535. https:\/\/doi.org\/10.1016\/s1074-7613(02)00423-5.","DOI":"10.1016\/s1074-7613(02)00423-5"},{"key":"1059_CR35","doi-asserted-by":"publisher","unstructured":"Mohamed RA, Shouman MM. Ondansetron alleviates testosterone-induced BPH in rats through cross regulation of the 5-HT\/AR\/P-STAT3 and the non-canonical NF-kappaB pathways. Eur J Pharmacol. 2025;991:177331. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177331.","DOI":"10.1016\/j.ejphar.2025.177331"},{"issue":"1","key":"1059_CR36","doi-asserted-by":"publisher","first-page":"17910.10.1038\/s","DOI":"10.1038\/s41598-023-44954-2","volume":"13","author":"P Wei","year":"2023","unstructured":"Wei P, Lin D, Luo C, Zhang M, Deng B, Cui K, Chen Z. High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expression. Sci Rep. 2023;13(1):17910. https:\/\/doi.org\/10.1038\/s41598-023-44954-2.","journal-title":"Sci Rep"},{"issue":"1","key":"1059_CR37","doi-asserted-by":"publisher","first-page":"112145.10.1016\/","DOI":"10.1016\/j.yexcr.2020.112145","volume":"394","author":"T Yang","year":"2020","unstructured":"Yang T, Zhou Y, Wang H, Chen S, Shen M, Hu Y, Wang T, Liu J, Jiang Z, Wang Z, Zhu X, Qian S, Yin X, Lu Q. Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK\/ERK signaling pathway. Exp Cell Res. 2020;394(1):112145. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112145.","journal-title":"Exp Cell Res"},{"issue":"6","key":"1059_CR38","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.juro.2017.06.080","volume":"198","author":"KJ Cho","year":"2017","unstructured":"Cho KJ, Koh JS, Choi J, Kim JC. Changes in adenosine triphosphate and nitric oxide in the urothelium of patients with benign prostatic hyperplasia and detrusor underactivity. J Urol. 2017;198(6):1392\u20136. https:\/\/doi.org\/10.1016\/j.juro.2017.06.080.","journal-title":"J Urol"},{"issue":"4","key":"1059_CR39","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","volume":"60","author":"M Gacci","year":"2011","unstructured":"Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol. 2011;60(4):809\u201325. https:\/\/doi.org\/10.1016\/j.eururo.2011.06.037.","journal-title":"Eur Urol"},{"issue":"7","key":"1059_CR40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.tcb.2019.03.007","volume":"29","author":"T Becker","year":"2019","unstructured":"Becker T, Song J, Pfanner N. Versatility of preprotein transfer from the cytosol to mitochondria. Trends Cell Biol. 2019;29(7):534\u201348. https:\/\/doi.org\/10.1016\/j.tcb.2019.03.007.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"1059_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nrm.2017.115","volume":"19","author":"J Soutourina","year":"2018","unstructured":"Soutourina J. Transcription regulation by the Mediator complex. Nat Rev Mol Cell Biol. 2018;19(4):262\u201374. https:\/\/doi.org\/10.1038\/nrm.2017.115.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"1059_CR42","doi-asserted-by":"publisher","first-page":"771\u2013783.10.1002","DOI":"10.1002\/JLB.1MR0622-473RR","volume":"112","author":"Y Li","year":"2022","unstructured":"Li Y, Chen M, Chang W. Roles of the nucleus in leukocyte migration. J Leukoc Biol. 2022;112(4):771\u2013783. https:\/\/doi.org\/10.1002\/JLB.1MR0622-473RR.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"1059_CR43","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1002\/bab.2513","volume":"70","author":"Y Cardenas-Moreno","year":"2023","unstructured":"Cardenas-Moreno Y, Gonzalez-Bacerio J, Garcia Arellano H, Del Monte-Martinez A. Oxidoreductase enzymes: characteristics, applications, and challenges as a biocatalyst. Biotechnol Appl Biochem. 2023;70(6):2108\u201335. https:\/\/doi.org\/10.1002\/bab.2513.","journal-title":"Biotechnol Appl Biochem"},{"issue":"7\u20138","key":"1059_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1101\/gad.335679.119","volume":"34","author":"AC Schier","year":"2020","unstructured":"Schier AC, Taatjes DJ. Structure and mechanism of the rna polymerase ii transcription machinery. Genes Dev. 2020;34(7\u20138):465\u201388. https:\/\/doi.org\/10.1101\/gad.335679.119.","journal-title":"Genes Dev"},{"key":"1059_CR45","doi-asserted-by":"publisher","unstructured":"Vogt AS, Arsiwala T, Mohsen M, Vogel M, Manolova V, Bachmann MF. On iron metabolism and its regulation. Int J Mol Sci. 2021;22(9). https:\/\/doi.org\/10.3390\/ijms22094591.","DOI":"10.3390\/ijms22094591"},{"issue":"19","key":"1059_CR46","doi-asserted-by":"publisher","first-page":"10235","DOI":"10.1039\/D2FO00841F","volume":"13","author":"YJ Choi","year":"2022","unstructured":"Choi YJ, Fan M, Wedamulla NE, Tang Y, Bae SM, Hwang JY, Kim EK. Inhibitory effects of centella asiatica (L.) urban on enlarged prostate through androgen receptor and PI3K\/Akt signaling pathways. Food Funct. 2022;13(19):10235\u201347. https:\/\/doi.org\/10.1039\/d2fo00841f.","journal-title":"Food Funct"},{"key":"1059_CR47","doi-asserted-by":"publisher","unstructured":"Jang J, Song J, Lee J, Moon SK, Moon B. Resveratrol attenuates the proliferation of prostatic stromal cells in benign prostatic hyperplasia by regulating cell cycle progression, apoptosis, signaling pathways, BPH markers, and NF- kappaB activity. Int J Mol Sci. 2021;22(11). https:\/\/doi.org\/10.3390\/ijms22115969.","DOI":"10.3390\/ijms22115969"},{"issue":"4","key":"1059_CR48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","volume":"62","author":"J Uribarri","year":"2007","unstructured":"Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007;62(4):427\u201333. https:\/\/doi.org\/10.1093\/gerona\/62.4.427.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1059_CR49","doi-asserted-by":"publisher","first-page":"585\u2013598.10.1007","DOI":"10.1007\/s11010-020-03928-y","volume":"476","author":"BN Waghela","year":"2021","unstructured":"Waghela BN, Vaidya FU, Ranjan K, Chhipa AS, Tiwari BS, Pathak C. AGE-RAGE synergy influences programmed cell death signaling to promote cancer. Mol Cell Biochem. 2021;476(2):585\u2013598. https:\/\/doi.org\/10.1007\/s11010-020-03928-y.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"1059_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3892\/ijo.2018.4420","volume":"53","author":"J Zhang","year":"2018","unstructured":"Zhang J, Shao S, Han D, Xu Y, Jiao D, Wu J, Yang F, Ge Y, Shi S, Li Y, Wen W, Qin W. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE\/NF-kappaB signaling pathway. Int J Oncol. 2018;53(2):659\u201371. https:\/\/doi.org\/10.3892\/ijo.2018.4420.","journal-title":"Int J Oncol"},{"issue":"7","key":"1059_CR51","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jnutbio.2009.04.001","volume":"21","author":"CM Lin","year":"2010","unstructured":"Lin CM, Chiu JH, Wu IH, Wang BW, Pan CM, Chen YH. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1 alpha. J Nutr Biochem. 2010;21(7):627\u201333. https:\/\/doi.org\/10.1016\/j.jnutbio.2009.04.001.","journal-title":"J Nutr Biochem"},{"issue":"14","key":"1059_CR52","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/pros.20641","volume":"67","author":"SE Park","year":"2007","unstructured":"Park SE, Park JW, Cho YS, Ryu JH, Paick JS, Chun YS. HIF-1alpha promotes survival of prostate cells at a high zinc environment. Prostate. 2007;67(14):1514\u201323. https:\/\/doi.org\/10.1002\/pros.20641.","journal-title":"Prostate"},{"issue":"1","key":"1059_CR53","first-page":"295","volume":"12","author":"Y Chen","year":"2019","unstructured":"Chen Y, Xu H, Shi Q, Gu M, Wan X, Chen Q, Wang Z. Hypoxia-inducible factor 1alpha (HIF-1alpha) mediates the epithelial-mesenchymal transition in benign prostatic hyperplasia. Int J Clin Exp Pathol. 2019;12(1):295\u2013304.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"1059_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5213\/inj.2040444.222","volume":"25","author":"TJ Cho","year":"2021","unstructured":"Cho TJ, Lee DH, Choi BH, Shinn HK, Park CS. Hypoxia-induced suppression of Antiapoptotic Bcl-2 expression in human bladder tumor cells is regulated by caveolin-1-dependent adenosine monophosphate-activated protein kinase activity. Int Neurourol J. 2021;25(2):137\u201349. https:\/\/doi.org\/10.5213\/inj.2040444.222.","journal-title":"Int Neurourol J"},{"issue":"10","key":"1059_CR55","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"A Iwasaki","year":"2004","unstructured":"Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5(10):987\u201395. https:\/\/doi.org\/10.1038\/ni1112.","journal-title":"Nat Immunol"},{"issue":"1\u20132","key":"1059_CR56","doi-asserted-by":"publisher","first-page":"61\u201379.10.1016\/s","DOI":"10.1016\/s0165-0378(02)00019-0","volume":"57","author":"AJ Quayle","year":"2002","unstructured":"Quayle AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol. 2002;57(1\u20132):61\u201379. https:\/\/doi.org\/10.1016\/s0165-0378(02)00019-0.","journal-title":"J Reprod Immunol"},{"issue":"3","key":"1059_CR57","doi-asserted-by":"publisher","first-page":"243\u2013249.10.1007","DOI":"10.1007\/s11934-008-0042-z","volume":"9","author":"S Sutcliffe","year":"2008","unstructured":"Sutcliffe S, Platz EA. Inflammation and prostate cancer: a focus on infections. Curr Urol Rep. 2008;9(3):243\u2013249. https:\/\/doi.org\/10.1007\/s11934-008-0042-z.","journal-title":"Curr Urol Rep"},{"issue":"12","key":"1059_CR58","doi-asserted-by":"publisher","first-page":"6973\u20136981.10.11","DOI":"10.1128\/IAI.00593-06","volume":"74","author":"JP Mackern-Oberti","year":"2006","unstructured":"Mackern-Oberti JP, Maccioni M, Cuffini C, Gatti G, Rivero VE. Susceptibility of prostate epithelial cells to chlamydia muridarum infection and their role in innate immunity by recruitment of intracellular Toll-like receptors 4 and 2 and MyD88 to the inclusion. Infect Immun. 2006;74(12):6973\u20136981. https:\/\/doi.org\/10.1128\/IAI.00593-06.","journal-title":"Infect Immun"},{"issue":"5","key":"1059_CR59","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1189\/jlb.1005597","volume":"79","author":"G Gatti","year":"2006","unstructured":"Gatti G, Rivero V, Motrich RD, Maccioni M. Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation. J Leukoc Biol. 2006;79(5):989\u201398. https:\/\/doi.org\/10.1189\/jlb.1005597.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1059_CR60","doi-asserted-by":"publisher","first-page":"179\u2013187.10.1007","DOI":"10.1007\/s43440-019-00010-3","volume":"72","author":"FB Calmasini","year":"2020","unstructured":"Calmasini FB, McCarthy CG, Wenceslau CF, Priviero FBM, Antunes E, Webb RC. Toll-like receptor 9 regulates metabolic profile and contributes to obesity-induced benign prostatic hyperplasia in mice. Pharmacol Rep. 2020;72(1):179\u2013187. https:\/\/doi.org\/10.1007\/s43440-019-00010-3.","journal-title":"Pharmacol Rep"},{"key":"1059_CR61","doi-asserted-by":"publisher","unstructured":"Li M, Zhang R, Li J, Li J. The role of C-Type lectin receptor signaling in the intestinal microbiota-inflammation-cancer axis. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.894445.","DOI":"10.3389\/fimmu.2022.894445"},{"issue":"12","key":"1059_CR62","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1002\/eji.201444876","volume":"44","author":"S Cohen-Kedar","year":"2014","unstructured":"Cohen-Kedar S, Baram L, Elad H, Brazowski E, Guzner-Gur H, Dotan I. Human intestinal epithelial cells respond to beta-glucans via dectin-1 and Syk. Eur J Immunol. 2014;44(12):3729\u201340. https:\/\/doi.org\/10.1002\/eji.201444876.","journal-title":"Eur J Immunol"},{"key":"1059_CR63","doi-asserted-by":"publisher","unstructured":"Rios-Covian D, Gonzalez S, Nogacka AM, Arboleya S, Salazar N, Gueimonde M, de Los Reyes-Gavilan CG. An overview on fecal branched short-chain fatty acids along human life and as related with body mass index: associated dietary and anthropometric factors. Front Microbiol. 2020;973(11). https:\/\/doi.org\/10.3389\/fmicb.2020.00973.","DOI":"10.3389\/fmicb.2020.00973"},{"key":"1059_CR64","doi-asserted-by":"publisher","unstructured":"Tirosh A, Calay ES, Tuncman G, Claiborn KC, Inouye KE, Eguchi K, Alcala M, Rathaus M, Hollander KS, Ron I, Livne R, Heianza Y, Qi L, Shai I, Garg R, Hotamisligil GS. The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans. Sci Transl Med. 2019;11(489). https:\/\/doi.org\/10.1126\/scitranslmed.aav0120.","DOI":"10.1126\/scitranslmed.aav0120"},{"issue":"1\u20132","key":"1059_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2006.01.019","volume":"370","author":"H Nandeesha","year":"2006","unstructured":"Nandeesha H, Koner BC, Dorairajan LN, Sen SK. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta. 2006;370(1\u20132):89\u201393. https:\/\/doi.org\/10.1016\/j.cca.2006.01.019.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"1059_CR66","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.18632\/aging.202968","volume":"13","author":"W Ratajczak","year":"2021","unstructured":"Ratajczak W, Mizerski A, Ryl A, Slojewski M, Sipak O, Piasecka M, Laszczynska M. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS). Aging (Albany NY). 2021;13(8):10934\u201354. https:\/\/doi.org\/10.18632\/aging.202968.","journal-title":"Aging (albany NY)"},{"key":"1059_CR67","doi-asserted-by":"publisher","unstructured":"Janeiro MH, Ramirez MJ, Milagro FI, Martinez JA, Solas M. Implication of trimethylamine N-Oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients. 2018;10(10). https:\/\/doi.org\/10.3390\/nu10101398.","DOI":"10.3390\/nu10101398"},{"issue":"2","key":"1059_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3945\/jn.115.220103","volume":"146","author":"S Rohrmann","year":"2016","unstructured":"Rohrmann S, Linseisen J, Allenspach M, von Eckardstein A, Muller D. Plasma concentrations of trimethylamine-N-oxide are directly associated with dairy food consumption and low-grade inflammation in a German adult population. J Nutr. 2016;146(2):283\u20139. https:\/\/doi.org\/10.3945\/jn.115.220103.","journal-title":"J Nutr"},{"key":"1059_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","volume":"70","author":"A Fiore","year":"2021","unstructured":"Fiore A, Murray PJ. Tryptophan and indole metabolism in immune regulation. Curr Opin Immunol. 2021;70:7\u201314. https:\/\/doi.org\/10.1016\/j.coi.2020.12.001.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1059_CR70","doi-asserted-by":"publisher","first-page":"15428.10.1038\/s","DOI":"10.1038\/s41598-017-15832-5","volume":"7","author":"E Carvalho-Dias","year":"2017","unstructured":"Carvalho-Dias E, Miranda A, Martinho O, Mota P, Costa A, Nogueira-Silva C, Moura RS, Alenina N, Bader M, Autorino R, Lima E, Correia-Pinto J. Serotonin regulates prostate growth through androgen receptor modulation. Sci Rep. 2017;7(1):15428. https:\/\/doi.org\/10.1038\/s41598-017-15832-5.","journal-title":"Sci Rep"},{"key":"1059_CR71","doi-asserted-by":"publisher","unstructured":"Fang Z, Pan T, Li L, Wang H, Zhu J, Zhang H, Zhao J, Chen W, Lu W. Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis. Gut Microbes. 2022;14(1):2044723. https:\/\/doi.org\/10.1080\/19490976.2022.2044723.","DOI":"10.1080\/19490976.2022.2044723"},{"key":"1059_CR72","doi-asserted-by":"publisher","unstructured":"Ferrari S, Galla R, Mule S, Uberti F. Analysis of the beneficial effects of probiotics on the gut-prostate axis using prostatic co-culture Model. Foods. 2024;13(22). https:\/\/doi.org\/10.3390\/foods13223647.","DOI":"10.3390\/foods13223647"},{"issue":"7682","key":"1059_CR73","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP, Fischbach MA, Sonnenburg JL. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551(7682):648\u201352. https:\/\/doi.org\/10.1038\/nature24661.","journal-title":"Nature"},{"key":"1059_CR74","doi-asserted-by":"publisher","unstructured":"Krause FF, Mangold KI, Ruppert AL, Leister H, Hellhund-Zingel A, Lopez Krol A, Pesek J, Watzer B, Winterberg S, Raifer H, Binder K, Kinscherf R, Walker A, Nockher WA, Taudte RV, Bertrams W, Schmeck B, Kuhl AA, Siegmund B, Romero R, Luu M, Gottig S, Bekeredjian-Ding I, Steinhoff U, Schutz B, Visekruna A. Clostridium sporogenes-derived metabolites protect mice against colonic inflammation. Gut Microbes. 2024;16(1). https:\/\/doi.org\/10.1080\/19490976.2024.2412669.","DOI":"10.1080\/19490976.2024.2412669"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01059-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:03:24Z","timestamp":1770725004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01059-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01059-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study type does not require an ethics statement and does not use human or animal subjects or materials.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}